Urgent, Comprehensive Federal Action Needed To Stem Mortality and Medicare Costs Associated With Antimicrobial Resistance.
Publication
, Journal Article
Fowler, VG; Jezek, A; Spivak, ES; Talkington, K
Published in: Clin Infect Dis
March 23, 2022
This paper is a call to action for the policies necessary to reduce the burden of antimicrobial resistance, including federal investments in antibiotic stewardship, antibiotic innovation, surveillance, research, diagnostics, infection prevention, the infectious diseases workforce, and global coordination.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
March 23, 2022
Volume
74
Issue
6
Start / End Page
1107 / 1111
Location
United States
Related Subject Headings
- United States
- Microbiology
- Medicare
- Humans
- Drug Resistance, Bacterial
- Communicable Diseases
- Antimicrobial Stewardship
- Anti-Bacterial Agents
- Aged
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Fowler, V. G., Jezek, A., Spivak, E. S., & Talkington, K. (2022). Urgent, Comprehensive Federal Action Needed To Stem Mortality and Medicare Costs Associated With Antimicrobial Resistance. Clin Infect Dis, 74(6), 1107–1111. https://doi.org/10.1093/cid/ciab697
Fowler, Vance G., Amanda Jezek, Emily S. Spivak, and Kathy Talkington. “Urgent, Comprehensive Federal Action Needed To Stem Mortality and Medicare Costs Associated With Antimicrobial Resistance.” Clin Infect Dis 74, no. 6 (March 23, 2022): 1107–11. https://doi.org/10.1093/cid/ciab697.
Fowler VG, Jezek A, Spivak ES, Talkington K. Urgent, Comprehensive Federal Action Needed To Stem Mortality and Medicare Costs Associated With Antimicrobial Resistance. Clin Infect Dis. 2022 Mar 23;74(6):1107–11.
Fowler, Vance G., et al. “Urgent, Comprehensive Federal Action Needed To Stem Mortality and Medicare Costs Associated With Antimicrobial Resistance.” Clin Infect Dis, vol. 74, no. 6, Mar. 2022, pp. 1107–11. Pubmed, doi:10.1093/cid/ciab697.
Fowler VG, Jezek A, Spivak ES, Talkington K. Urgent, Comprehensive Federal Action Needed To Stem Mortality and Medicare Costs Associated With Antimicrobial Resistance. Clin Infect Dis. 2022 Mar 23;74(6):1107–1111.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
March 23, 2022
Volume
74
Issue
6
Start / End Page
1107 / 1111
Location
United States
Related Subject Headings
- United States
- Microbiology
- Medicare
- Humans
- Drug Resistance, Bacterial
- Communicable Diseases
- Antimicrobial Stewardship
- Anti-Bacterial Agents
- Aged
- 3202 Clinical sciences